$606M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | CGON Cg Oncology Inc | 1.9M | +2389.8% | $134M | 22.1% |
| 2 | TNGX Tango Therapeutics Inc | 3.2M | +543.0% | $96M | 15.8% |
| 3 | RVMD Revolution Medicines Inc | 242,029 | +199.6% | $45M | 7.5% |
| 4 | PHVS Pharvaris N V | 774,501 | +348.4% | $27M | 4.4% |
| 5 | LQDA Liquidia Corporation | 256,603 | +36.6% | $20M | 3.4% |
| 6 | ELVN Enliven Therapeutics Inc | 365,386 | +122.8% | $19M | 3.1% |
| 7 | ABIVAX SA Abivax Sa | 111,334 | +158.6% | $15M | 2.4% |
| 8 | AVTX Avalo Therapeutics Inc | 770,765 | +260.5% | $14M | 2.4% |
| 9 | MIRM Mirum Pharmaceuticals Inc | 110,393 | — | $13M | 2.1% |
| 10 | ASMB Assembly Biosciences Inc | 433,147 | +671.5% | $12M | 2.0% |
| 11 | IPSC Century Therapeutics Inc | 4.3M | +47.5% | $11M | 1.8% |
| 12 | CYTK Cytokinetics Inc | 118,240 | +93.0% | $10M | 1.7% |
| 13 | TSHA Taysha Gene Therapies Inc | 1.5M | +140.4% | $10M | 1.6% |
| 14 | MANE Veradermics Inc | 80,000 | — | $10M | 1.6% |
| 15 | AVBP Arrivent Biopharma Inc | 246,606 | +390.7% | $9M | 1.4% |
| 16 | TARS Tarsus Pharmaceuticals Inc | 117,067 | +491.2% | $8M | 1.3% |
| 17 | XNCR Xencor Inc | 368,305 | +360.4% | $8M | 1.3% |
| 18 | ROIV Roivant Sciences Ltd | 220,126 | +71.7% | $8M | 1.3% |
| 19 | DMRA Damora Therapeutics Inc | 284,430 | +180.9% | $7M | 1.2% |
| 20 | AXSM Axsome Therapeutics Inc. | 28,826 | +105.1% | $7M | 1.2% |
| 21 | DFTX Definium Therapeutics Inc | 148,647 | +48.8% | $7M | 1.2% |
| 22 | DNTH Dianthus Therapeutics Inc | 64,723 | +19.3% | $6M | 1.0% |
| 23 | COGT Cogent Biosciences Inc | 147,510 | −1.3% | $6M | 0.9% |
| 24 | ERAS Erasca Inc | 308,007 | +38.5% | $6M | 0.9% |
| 25 | PTGX Protagonist Therapeutics Inc | 45,400 | +1035.0% | $6M | 0.9% |
| 26 | NERV Minerva Neurosciences Inc | 1.0M | +303.0% | $6M | 0.9% |
| 27 | EDIT Editas Medicine Inc | 1.3M | — | $4M | 0.7% |
| 28 | CTMX Cytomx Therapeutics Inc. | 1.1M | +192.2% | $4M | 0.7% |
| 29 | EPRX Eupraxia Pharmaceuticals Inc | 610,785 | +40.9% | $4M | 0.7% |
| 30 | STRO Sutro Biopharma Inc | 159,118 | — | $4M | 0.6% |
| 31 | RLAY Relay Therapeutics Inc | 178,222 | −30.9% | $3M | 0.6% |
| 32 | CLDX Celldex Therapeutics Inc New | 86,664 | +195.8% | $3M | 0.5% |
| 33 | ASND Ascendis Pharma A/S | 11,869 | — | $3M | 0.5% |
| 34 | SGMT Sagimet Biosciences Inc | 403,545 | — | $3M | 0.5% |
| 35 | ZLAB Zai Lab Ltd | 136,016 | +74.7% | $3M | 0.5% |
| 36 | SABS Sab Biotherapeutics Inc | 736,077 | +636.1% | $3M | 0.5% |
| 37 | MDGL Madrigal Pharmaceuticals Inc | 4,973 | +46.6% | $3M | 0.4% |
| 38 | PRAX Praxis Precision Medicines I | 7,540 | — | $3M | 0.4% |
| 39 | RLMD Relmada Therapeutics Inc | 348,265 | — | $2M | 0.4% |
| 40 | AGIO Agios Pharmaceuticals Inc | 56,900 | −72.8% | $2M | 0.3% |
| 41 | XENE Xenon Pharmaceuticals Inc | 33,300 | — | $2M | 0.3% |
| 42 | SVRA Savara Inc | 309,103 | +4.5% | $2M | 0.3% |
| 43 | CCCC C4 Therapeutics Inc | 381,169 | +567.8% | $2M | 0.3% |
| 44 | PCVX Vaxcyte Inc | 29,800 | −72.5% | $2M | 0.3% |
| 45 | CELC Celcuity Inc | 16,252 | +170.9% | $2M | 0.3% |
| 46 | SNDX Syndax Pharmaceuticals Inc | 77,930 | — | $2M | 0.3% |
| 47 | ZNTL Zentalis Pharmaceuticals Inc | 317,600 | +188.7% | $1M | 0.2% |
| 48 | GPCR Structure Therapeutics Inc | 26,800 | +197.8% | $1M | 0.2% |
| 49 | LONA Leonabio Inc | 154,153 | −6.4% | $1M | 0.2% |
| 50 | IDYA Ideaya Biosciences Inc | 37,865 | −56.1% | $1M | 0.2% |